Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Busyzzindahouseon Dec 02, 2016 4:05pm

124 Views

Post# 25548689

onwards and upwards from here

Wow wow wow.... that was some bullish reversal..... If you all remember i had been screaming since yesterday that this was oversold and it would bounce..... glad it did...... i would like to mention though that we should be realistic in our expectation of this from here...... remember what ever your target price, it is now a target price of the US operation.....what the market prices it at is different from what it is really worth.....my target price as i have said earlier for NF without debt is around 23-26 cents...... market might price it higher...... anyways folks, it was a horrible week ......but glad it ends on a high.......... SEEEEE YAAALLLL MONDAYYYY

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages